Dr. Santhosshi Narayanan, MD

Dr. Narayanan practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Narayanan's NPI, 1164678439, was assigned on August 18, 2008. Dr. Narayanan graduated from Stanley Medical College SMC in 2006. Dr. Narayanan's Texas license number on file is P4491.

Dr. Narayanan's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Narayanan's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Narayanan practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Narayanan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Narayanan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Narayanan's licenses on file in 13 states: Texas, Florida, Arizona, Tennessee, Washington, Georgia, Louisiana, Mississippi, Alabama, Oklahoma, Indiana, Michigan and Ohio.

Dmand AI lists adjustment disease, fibromyalgia and chronic pain, itchy rashes, lower back pain, muscle pain, fibromyalgia, and limb pain, neuropathy, sleep apnea and vitamin d deficiency among the conditions Dr. Narayanan treats.

CMS data shows 190 Medicare services from Dr. Narayanan across 6 procedure codes in 2024, for 195 Medicare patients. Medicare paid $15,514 for them.

CMS counts 195 Medicare patients who saw Dr. Narayanan in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Narayanan's median patient age at 58, with 72% women.

In 2017, Dr. Narayanan wrote 38 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $887 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Narayanan for performance year 2024, reported as part of a group. Dr. Narayanan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Narayanan as offering telehealth.

Dmand AI links 51 papers to Dr. Narayanan, published from 2013 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Integrative Oncology, Breast Neoplasms and COVID-19. Dr. Narayanan has published most often in Integr Cancer Ther. Dr. Narayanan's most frequent co-authors are Eduardo D. Bruera, MD, Wenli Liu, MD and Akhila S. Reddy, MD.

Dmand AI links Dr. Narayanan to 2 clinical trials. 1 is still active or recruiting. Conditions studied include COVID-19 and Pneumonia, Viral. M.D. Anderson Cancer Center sponsors the most, 2.

CMS Open Payments shows 2 general payments to Dr. Narayanan from 2 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $93.

Dr. Narayanan graduated from Stanley Medical College SMC in 2006. Dr. Narayanan is a member of SHM.

Dr. Narayanan is in network with 4 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.